中恒集团项目荣膺华夏医学科技奖

Core Viewpoint - The project led by Wuzhou Pharmaceutical, a subsidiary of Zhongheng Group, won the third prize at the 2025 Huaxia Medical Science and Technology Award, marking a significant recognition in the field of traditional Chinese medicine [1] Group 1: Award Details - The project titled "Key Technology Innovation and Advanced Manufacturing Application Based on Standardization of Traditional Chinese Medicine" is the only one focused on the industrial application of traditional Chinese medicine among the award winners [1] - Wuzhou Pharmaceutical is the only award-winning unit from Guangxi and the only leading unit represented by a traditional Chinese medicine enterprise [1] - The Huaxia Medical Science and Technology Award is a national-level award recognized by the Ministry of Science and Technology, serving as an important benchmark for evaluating research strength in the medical and health fields [1] Group 2: Project Significance - The project stood out due to multiple internationally leading technological breakthroughs and significant industrial value, indicating Zhongheng Group's achievements in the standardization and advanced manufacturing of traditional Chinese medicine [1] - The award reflects the national-level recognition of Zhongheng Group's contributions to the field, emphasizing the importance of continued innovation and technology development in traditional Chinese medicine [1] - Zhongheng Group plans to deepen its core technology research in traditional Chinese medicine and promote the transformation of its achievements to contribute to the high-quality development of traditional Chinese medicine [1]